Llwytho...
Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1
IMPORTANCE: Therapies to inhibit programmed cell death 1 and its ligand (anti–PD-1/PD-L1) provide significant survival benefits in many cancers, but the efficacy of these treatments varies considerably across different cancer types. Identifying the underlying variables associated with this cancer ty...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | JAMA Oncol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Medical Association
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6707018/ https://ncbi.nlm.nih.gov/pubmed/31436822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.2311 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|